2023
Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
PubMed, Renal cell carcinoma treatment
UniversitiesVictor Okebalama
Active, last published 2026
Victor
Okebalama
“Research profile drawn from open scholarly records.”
Babcock University
Claim Your Profile0
H-index
0
Citations
Victor has not officially claimed their profile. If you are Victor, claim it free.
Claim Your Profile01 · About the work
What I study
research summary for Victor Okebalama will appear here once their profile is updated.
02 · Reach
Publication output and reach
Victor's work has been cited 0 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
06 · Where I am
Affiliations
CurrentlyBabcock University
Research themes (UN SDGs)
07 · Selected work
Recent publications
View all 6 works2023Open access
Endometrial carcinoma with co-existing granulosa cell tumour in a post-menopausal woman: a case reportBabcock University Medical Journal, Ovarian cancer diagnosis and treatment
2024Open access
Bilateral ovarian mature cystic teratoma co-existing with granulosa cell tumour: a case reportBabcock University Medical Journal, Ovarian cancer diagnosis and treatment
2024Open access
Malignant Phyllodes Tumor: Report of Two Cases and Review of LiteraturePubMed, Breast Lesions and Carcinomas
2024Open access
Atypical (symplastic) uterine leiomyoma masquerading as endometrial malignancy in a 78-year-old post-menopausal Nigerian womanBabcock University Medical Journal, Uterine Myomas and Treatments
Are you Victor?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required